• Mi Re-Unir
    Búsqueda Avanzada
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Ver ítem 
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem
    •   Inicio
    • RESULTADOS DE INVESTIGACIÓN
    • Artículos Científicos WOS y SCOPUS
    • Ver ítem

    The time to offer treatments for COVID-19

    Autor: 
    Ngo, Binh T.
    ;
    Marik, Paul
    ;
    Kory, Pierre
    ;
    Shapiro, Leland
    ;
    Thomadsen, Raphael
    ;
    Iglesias, Jose
    ;
    Ditmore, Stephen
    ;
    Rendell, Marc
    ;
    Varon, Joseph
    ;
    Dube, Michael
    ;
    Nanda, Neha
    ;
    In, Gino K.
    ;
    Arkfeld, Daniel
    ;
    Chaudhary, Preet
    ;
    Campese, Vito M.
    ;
    Hanna, Diana L.
    ;
    Sawcer, David E.
    ;
    Ehresmann, Glenn
    ;
    Peng, David
    ;
    Smorgorzewski, Miroslaw
    ;
    Armstrong, April
    ;
    Dasgupta, Rajkumar
    ;
    Sattler, Fred R.
    ;
    Brennan-Rieder, Denise
    ;
    Mussini, Cristina
    ;
    Mitjà, Oriol
    ;
    Soriano, Vicente (1)
    ;
    Peschanski, Nicolas
    ;
    Hayem, Gilles
    ;
    Confalonieri, Marco
    ;
    Piccirillo, Maria Carmela
    ;
    Lobo-Ferreira, António
    ;
    Bello Rivero, Iraldo
    ;
    Turkia, Mika
    ;
    Vinjevoll, Eivind H.
    ;
    Griffin, Daniel O.
    ;
    Hung, Ivan Fn
    Fecha: 
    2021
    Palabra clave: 
    SARS-Cov-2; covid-19; hcq; remdesivir; favipiravir; interferon-λ; interferon-β; -1; convalescent plasma; synthetic anti-spike protein antibodies; ivermectin; WOS(2); Scopus
    Tipo de Ítem: 
    article
    URI: 
    https://reunir.unir.net/handle/123456789/12163
    DOI: 
    https://doi.org/10.1080/13543784.2021.1901883
    Dirección web: 
    https://www.tandfonline.com/doi/full/10.1080/13543784.2021.1901883
    Open Access
    Resumen:
    Background: COVID-19 has several overlapping phases. Treatments to date have focused on the late stage of disease in hospital. Yet, the pandemic is by propagated by the viral phase in out-patients. The current public health strategy relies solely on vaccines to prevent disease.Methods: We searched the major national registries, pubmed.org, and the preprint servers for all ongoing, completed and published trial results.Results: As of 2/15/2021, we found 111 publications reporting findings on 14 classes of agents, and 9 vaccines. There were 62 randomized controlled studies, the rest retrospective observational analyses. Only 21 publications dealt with outpatient care. Remdesivir and high titer convalescent plasma have emergency use authorization for hospitalized patients in the U.S.A. There is also support for glucocorticoid treatment of the COVID-19 respiratory distress syndrome. Monoclonal antibodies are authorized for outpatients, but supply is inadequate to treat all at time of diagnosis. Favipiravir, ivermectin, and interferons are approved in certain countries.Expert Opinion: Vaccines and antibodies are highly antigen specific, and new SARS-Cov-2 variants are appearing. We call on public health authorities to authorize treatments with known low-risk and possible benefit for outpatients in parallel with universal vaccination.
    Mostrar el registro completo del ítem
    Este ítem aparece en la(s) siguiente(s) colección(es)
    • Artículos Científicos WOS y SCOPUS

    Estadísticas de uso

    Año
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    Vistas
    0
    0
    0
    0
    0
    0
    0
    0
    0
    16
    20
    Descargas
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0
    0

    Ítems relacionados

    Mostrando ítems relacionados por Título, autor o materia.

    • The Importance of Understanding the Stages of COVID-19 in Treatment and Trials 

      Griffin, Daniel O.; Brennan-Rieder, Denise; Ngo, Binh; Kory, Pierre; Confalonieri, Marco; Shapiro, Leland; Iglesias, Jose; Dube, Michael; Nanda, Neha; In, Gino K.; Arkfeld, Daniel; Chaudhary, Preet; Campese, Vito M.; Hanna, Diana L.; Sawcer, David; Ehresmann, Glenn; Peng, David; Smorgorzewski, Miroslaw; Amstrong, April; Vinjevoll, Eivind H.; Dasgupta, Rajkumar; Sattler, Fred R.; Mussini, Cristina; Mitjà, Oriol; Soriano, Vicente (1); Peschanski, Nicolas; Hayem, Gilles; Piccirillo, Maria Carmela; Lobo-Ferreira, António; B. Rivero, Iraldo; Hung, Ivan F. H.; Rendell, Marc; Ditmore, Stephen; Varon, Joseph; Marik, Paul (AIDS reviews, 2021)
      COVID-19, caused by SARS-CoV-2, continues to be a major health problem since its first description in Wuhan, China, in December 2019. Multiple drugs have been tried to date in the treatment of COVID-19. Critical to treatment ...
    • Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study 

      Baenas, Isabel; Etxandi, Mikel; Munguía, Lucero; Granero, Roser; Mestre-Bach, Gemma (1); Sánchez, Isabel; Ortega, Emilio; Andreu, Alba; Moize, Violeta L.; Fernández-Real, Jose-Manuel; Tinahones, Francisco J.; Diéguez, Carlos; Frühbeck, Gema; Le Grange, Daniel; Tchanturia, Kate; Karwautz, Andreas; Zeiler, Michael; Imgart, Hartmut; Zanko, Annika; Favaro, Ángela; Claes, Laurence; Shekriladze, Ia; Serrano‐Troncoso, Eduardo; Cecilia-Costa, Raquel; Rangil, Teresa; Loran Meler, Maria Eulalia; Soriano‐Pacheco, José; Carceller‐Sindreu, Mar; Navarrete, Rosa; Lozano, Meritxell; Linares, Raquel; Gudiol, Carlota; Carratala, Jordi; Plana, María T.; Graell, Montserrat; González-Parra, David; Gómez-del Barrio, José A.; Sepúlveda, Ana R.; Sánchez-González, Jéssica; Machado, Paulo PP; Håkansson, Anders; Túry, Ferenc; Pászthy, Bea; Stein, Daniel; Papezová, Hana; Gricova, Jana; Bax, Brigita; Borisenkov, Mikhail F.; Popov, Sergey V.; Gubin, Denis G.; Petrov, Ivan M.; Isakova, Dilara; Mustafina, Svetlana V.; Kim, Youl‐Ri; Nakazato, Michiko; Godart, Nathalie; van Voren, Robert; Ilnytska, Tetiana; Chen, Jue; Rowlands, Katie; Voderholzer, Ulrich; Monteleone, Alessio M.; Treasure, Janet; Jiménez-Murcia, Susana; Fernández-Aranda, Fernando (Nutrients, 01/2022)
      Background. The COVID-19 lockdown has had a significant impact on mental health. Patients with eating disorders (ED) have been particularly vulnerable. Aims. (1) To explore changes in eating-related symptoms and general ...
    • Development of the HIV360 international core set of outcome measures for adults living with HIV: A consensus process 

      Marques-Gomes, João; Salt, Matthew J.; Pereira-Neto, Rita; Barteldes, Franca S.; Gouveia-Barros, Vera; Carvalho, Alexandre; d’Arminio-Monforte, Antonella; De-la-Torre-Rosas, Alethse; Harris, Amy; Esteves, Catarina; Maor, Carcom; Mora, Cristina; Oliveira, Carla; Sousa, Cristina; Richman, Douglas D.; Martinez, Esteban; Cota-Medeiros, Fábio; Gramacho, Filipa; Behrens, Georg M. N.; Gonçalves, Graça; Farinha, Helena; Nabais, Isabel; Vaz-Pinto, Inês; Sierra-Madero, Juan; Sousa-Gago, Joaquim; Thornhill, John; Vera, José; Erceg-Tusek, Maja; Tavares, Margarida; Vasconcelos, Miguel; Fernandes, Nuno; Gianotti, Nicola; Langebeek, Nienke; Anjos, Paulo; Couto, Raquel; Fernandes, Ricardo; Rajasuriar, Reena; Serrão, Rosário; Watson, Shaun; Branco, Teresa; Teixeira, Tiago; Soriano, Vicente (1) (John Wiley and Sons Inc, 2021)
      Objectives: HIV outcomes centre primarily around clinical markers with limited focus on patient-reported outcomes. With a global trend towards capturing the outcomes that matter most to patients, there is agreement that ...

    Mi cuenta

    AccederRegistrar

    ¿necesitas ayuda?

    Manual de UsuarioAutorización TFG-M

    Listar

    todo Re-UnirComunidades y coleccionesPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de accesoEsta colecciónPor fecha de publicaciónAutoresTítulosPalabras claveTipo documentoTipo de acceso






    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja
     
    Aviso Legal Política de Privacidad Política de Cookies Cláusulas legales RGPD
    © UNIR - Universidad Internacional de La Rioja